C07D 309/14
Nitrogen atoms not forming part of a nitro radical
C07D309/14 (Nitrogen atoms not forming part of a nitro radical) appears on 387 US grants and 492 published applications in this corpus.
Search patents in C07D- Granted patents
- 387
- Published applications
- 492
- Assignees
- 260
- Inventors
- 1,569
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 5 | 0 |
| 2001 | 11 | 1 |
| 2002 | 9 | 7 |
| 2003 | 10 | 19 |
| 2004 | 7 | 18 |
| 2005 | 5 | 22 |
| 2006 | 8 | 15 |
| 2007 | 4 | 20 |
| 2008 | 9 | 11 |
| 2009 | 15 | 24 |
| 2010 | 10 | 17 |
| 2011 | 12 | 17 |
| 2012 | 12 | 17 |
| 2013 | 20 | 15 |
| 2014 | 13 | 34 |
| 2015 | 23 | 27 |
| 2016 | 23 | 30 |
| 2017 | 33 | 30 |
| 2018 | 15 | 22 |
| 2019 | 24 | 20 |
| 2020 | 10 | 22 |
| 2021 | 15 | 13 |
| 2022 | 9 | 23 |
| 2023 | 8 | 19 |
| 2024 | 18 | 26 |
| 2025 | 11 | 14 |
| 2026 | 7 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Substituted cyclohexyl compounds as NOP inhibitors2 Jun 2026US 12,643,888 B2Dart NeuroScience, LLC
- Subtituted sulfonylurea and sulfoximineurea derivatives14 Apr 2026US 12,599,616 B2Zydus Lifesciences Limited
- Inhibitors of YAP/TAZ-TEAD oncoproteins, synthesis and use thereof24 Mar 2026US 12,583,815 B2BridGene Biosciences, Inc.
- Prostaglandin E2 (PGE2) EP4 receptor antagonists20 Jan 2026US 12,527,779 B2Domain Therapeutics
- Process for the preparation of sulfamoylbenzoic acid derivatives1 Oct 2026US 2026/0297022 A1Iama Therapeutics S.R.L.
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
- Noncovalent Keap1-Nrf2 Small-Molecule Inhibitors9 Jul 2026US 2026/0193170 A1University of Copenhagen
- Compounds and compositions for treating conditions associated with lpa receptor activity18 Jun 2026US 2026/0167607 A1Lhotse Bio, Inc.
- Anticancer drug conjugates4 Jun 2026US 2026/0151413 A1Ariel Scientific Innovations Ltd.
Most cited
By later US patents
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- 2-and 2,5-substituted phenylketoenols93US 6,114,374 ABayer Aktiengesellschaft · 2000
- Arylphenyl-substituted cyclic keto enols88US 6,451,843 B1Bayer Aktiengesellschaft · 2002
- Arylsulfonamido-substituted hydroxamic acids85US 5,552,419 ACiba-Geigy Corporation · 1996
- Selective estrogen receptor modulator79US 7,612,114 B2Eisai R&D Management Co., Ltd. · 2009